Advertisement

Nootrop wirkende Substanzen

Chapter
  • 11 Downloads

Zusammenfassung

Die Alzheimer-Krankheit ist die häufigste geriatrische Krankheit. 5% der über 65jährigen leiden daran. Diese Zahl steigt rapide mit dem Lebensalter an, und bei den über 80jährigen sind es schon über 10 bis 20%. Allerdings kann die Krankheit schon bei 35jährigen beginnen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. American Psychiatric Association (1995) 148th Annual Meeting. Topic 8: Organic Mental DisordersGoogle Scholar
  2. Bloom FE, Kupfer DJ (Hrsg.) (1995) Psychopharmacology. The Fourth Generation in Progress; Geriatric Disorders: 1361–1479; Raven, NYGoogle Scholar
  3. Clark R, Goate A (1993) Molecular genetics of Alzheimer’s disease. Arch Neurol 50: 1164–1172PubMedCrossRefGoogle Scholar
  4. Cohen RM, Weingartner HW, Smallberg A, Pickar D, Murphy DL (1982) Effort and cognition in depression. Arch Gen Psychiatry 39: 593–597PubMedCrossRefGoogle Scholar
  5. Davis KL, Thal LJ, Gamzu E (1992) Tacrine in patients with Alzheimer’s disease: a double blind placebo controlled multicenter study. N Engl J Med 327: 1374–1379CrossRefGoogle Scholar
  6. Hitzenberger G, Rameis H, Manigley C (1998) Pharmacological Properties of Pirace-tam. CNS Drugs, 9 suppl 1: 19–27CrossRefGoogle Scholar
  7. Freeman TW, Clothier JL, Pazzaglia P (1992) A Double-blind Comparison of Val-proate and Lithium in the Treatment of Acute Mania. Am J Psychiatry 149: 108–111PubMedGoogle Scholar
  8. Mohs RC (1991) Assessment of cognitive symptoms in clinical studies of antidementia drugs (Homma A. trans): Jpn J Geriatr Psychiatry 2: 1195–1201Google Scholar
  9. Pierpaoli W, Regelson W, Fabris N (Hrsg.) (1994) The Aging Clock; Ann NY Acad Sci 719Google Scholar
  10. Rapoport SI, Grady CL (1993) Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer’s disease. J Neurosci 70: 39–56Google Scholar
  11. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990) Evidence that ß-amyloid protein in Alzheimer’s disease is not derived by normal processing. Science 248: 492–495PubMedCrossRefGoogle Scholar

Copyright information

© Steinkopff Verlag, Darmstadt 1999

Authors and Affiliations

  1. 1.Klinik für PsychiatrieAllgemeines KrankenhausWienÖsterreich

Personalised recommendations